Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

A new report finds that a majority of Americans think the U.S. should be a world leader in science, but Democrats ...

Boston Scientific’s last mega-deal didn’t go so well. The medtech company with a large Minnesota presence acquired Arden ...

Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an ...

Boston Scientific has long used mergers and acquisitions to fuel growth. This deal appears to be its largest since its ...

Artificial intelligence promises to accelerate scientific discovery and open new frontiers of inquiry. But new research from ...

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst ...

Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Scientific uncertainty persists around 3I/ATLAS after anomalous observations and a CIA FOIA response, despite NASA’s public ...

The consequences could be severe. With paylines at most NIH Institutes well below 10 percent, every award not based on merit ...